Forced Expiratory Volume in 1 Second Variability Predicts Lung Transplant or Mortality in People with Cystic Fibrosis in the United States.

Rationale: Declines in percent predicted forced expiratory volume in 1 second (ppFEV₁) are an important marker of clinical progression of cystic fibrosis (CF). Objectives: We examined ppFEV₁ variability in relation to a combined outcome of lung transplant or death. Methods: We estimated the association between ppFEV₁ variability and the combined outcome of lung transplant or death. We included children aged 8 years and older with CF and two prior years of ppFEV₁ data before baseline between 2005 and 2021. We defined ppFEV₁ increased variability as any relative increase or decrease of at least 10% in ppFEV₁ from a 2-year averaged baseline. A marginal structural Cox proportional hazards model was used. We examined a cumulative measure of ppFEV₁ variability, defined as the cumulative proportion of visits with ppFEV₁ variability at each visit. Kaplan-Meier survival curves were generated on the basis of quartiles of the cumulative distribution of ppFEV₁ variability. Results: We included 9,706 patients with CF in our cohort. The median age at cohort entry was 8.3 (interquartile range, 8.2–8.4) years; 50% of patients were female; 94% were White; and the median baseline ppFEV₁ was 94.4 (interquartile range, 81.6–106.1). The unadjusted hazard ratio for increased ppFEV₁ variability on lung transplant/mortality was 4.13 (95% confidence interval, 3.48–4.90), and the weighted hazard ratio was 1.49 (95% confidence interval, 1.19–1.86). Survival curves stratified by quartile of cumulative variability demonstrated an increased hazard of lung transplant/mortality as the proportion of cumulative ppFEV₁ variability increased. Conclusions: We found a strong association between ppFEV₁ variability and lung transplant or mortality in a cohort of people with CF in the United States. [ABSTRACT FROM AUTHOR]